Skip to main navigation Skip to search Skip to main content

Study protocol for a double-blind randomised controlled trial investigating the impact of 12 weeks supplementation with a Fucus vesiculosus extract on cholesterol levels in adults with elevated fasting LDL cholesterol who are overweight or have obesity

  • Margaret Murray
  • , Aimee L. Dordevic
  • , Katherine H.M. Cox
  • , Andrew Scholey
  • , Lisa Ryan
  • , Maxine P. Bonham
    • Monash University
    • Swinburne University of Technology

    Research output: Contribution to journalArticlepeer-review

    16 Citations (Scopus)

    Abstract

    Introduction Hyperlipidaemia, hyperglycaemia and chronic inflammation are risk factors for chronic diseases cardiovascular disease and type 2 diabetes Polyphenols are bioactive compounds found in marine algae with potential antihyperlipidaemic, antihyperglycaemic and anti-inflammatory effects The modulation of these risk factors using bioactive polyphenols may represent a useful strategy for disease prevention and management; research in humans, however, remains limited This trial aims to determine the impact of a polyphenol-rich brown seaweed extract on fasting hyperlipidaemia, hyperglycaemia and inflammation Effects on mood and cognition will also be evaluated Methods and analysis Fifty-eight hypercholesterolaemic participants who are overweight or have obesity will be randomised to receive either a polyphenol-rich brown seaweed extract (2000 mg dose containing 600 mg polyphenols) or placebo (2000 mg rice flour) daily for 12 weeks Fasting venous blood samples will be taken at baseline, week 6 and week 12 of the intervention to assess serum cholesterol (total, low-density lipoprotein and high-density lipoprotein) and triglyceride concentrations, plasma glucose and insulin concentrations and markers of inflammation Mood and cognitive function will be evaluated as exploratory outcomes Independent t-tests or equivalent will be used to determine differences between the two groups in changes from baseline to week 12 Analysis of variance will be used to assess differences between the groups across the three time points (baseline, week 6 and week 12) Ethics and dissemination Ethics approval has been granted by the Monash University Human Research Ethics Committee (2017-8689-10379) Results from this trial will be disseminated through publication in peer-reviewed journals, national and international presentations, and a PhD thesis These results are essential to inform the use of polyphenol-rich brown seaweeds as a functional food or nutritional supplement ingredients for health promotion and disease prevention and management in humans.

    Original languageEnglish
    Article numbere022195
    JournalBMJ Open
    Volume8
    Issue number12
    DOIs
    Publication statusPublished - 1 Dec 2018

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being
    2. SDG 14 - Life Below Water
      SDG 14 Life Below Water

    Keywords

    • cognition
    • glycaemia
    • inflammation
    • lipids
    • polyphenol

    Fingerprint

    Dive into the research topics of 'Study protocol for a double-blind randomised controlled trial investigating the impact of 12 weeks supplementation with a Fucus vesiculosus extract on cholesterol levels in adults with elevated fasting LDL cholesterol who are overweight or have obesity'. Together they form a unique fingerprint.

    Cite this